StrongIncrease
Adiponectin
BeaT-2/Sugarburner → Adiponectin
BeaT-2/Sugarburner → Adiponectin
Evidence profile
StrongIncreaseMetabolic Health
Unlock full evidence details
Research Summary
Analyzed using Evidence Intelligence™
Probiotic supplement improves glycemic control in type 2 diabetes
Key finding
HbA1c decreased by 0.3%.
This study investigated the effects of a probiotic nutritional supplement on glycemic control in type 2 diabetes patients, revealing mixed results.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Some Concerns bias
Last updated July 6, 2026Quick read
Study at a glance
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
BeaT-2/Sugarburner, Placebo
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Primary outcome
HbA1c
Comparator
Placebo
Plain-language summary
What this paper says
A plain-language read of the study's main message and where it applies.
Study focus
This study investigated the effects of a probiotic nutritional supplement on glycemic control in type 2 diabetes patients, revealing mixed results.
Clinical relevance
Understanding the role of probiotics in managing type 2 diabetes could offer new therapeutic options for patients struggling with glycemic control. If proven effective, such supplements could enhance existing treatment strategies, potentially leading to better health outcomes.
Keep in mind
Limited sample size may affect generalizability. Inconsistent results across different outcomes. Lack of long-term follow-up data.
Published in
Journal Reference
Publication details and source links for this paper.
Andreas P, Pamela C, Mina RH, et al. The impact of a probiotic nutritional supplement on glycemic control in patients with type 2 diabetes: A randomized controlled trial. Nutrition and Metabolic Insights. 2026;19:11786388251413658. doi:10.1177/11786388251413658
Save this study and add notes to your research library.
Main Effects
HbA1c decreased by 0.3% (p=0.05)
Fasting plasma glucose decreased by 14% (p=0.05)
Insulin decreased by 17% (p=0.05)
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to BeaT-2/Sugarburner and Adiponectin, C-reactive protein, Fasting Plasma Glucose (FPG), and 4 more.
This study contributes evidence to
Primary intervention
BeaT-2/Sugarburner
Primary outcomes
- Adiponectin
- C-reactive protein
- Fasting Plasma Glucose (FPG)
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
7
Evidence pairs
7
Relationships
3
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
3
Related topics
7
Evidence pairs
298
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 7 evidence relationships
- Includes primary outcome data
- Linked to 3 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
Study findings
The primary outcomes reported in this study.
StrongDecrease
C-reactive protein
BeaT-2/Sugarburner → C-reactive protein
BeaT-2/Sugarburner → C-reactive protein
Evidence profile
StrongDecreaseMetabolic Health
Unlock full evidence details
StrongDecrease
Fasting Plasma Glucose (FPG)
BeaT-2/Sugarburner → Fasting Plasma Glucose (FPG)
BeaT-2/Sugarburner → Fasting Plasma Glucose (FPG)
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease
HbA1c
BeaT-2/Sugarburner → HbA1c
BeaT-2/Sugarburner → HbA1c
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease
Insulin
BeaT-2/Sugarburner → Insulin
BeaT-2/Sugarburner → Insulin
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease
Insulin resistance
BeaT-2/Sugarburner → Insulin resistance
BeaT-2/Sugarburner → Insulin resistance
Evidence profile
StrongDecreaseMetabolic Health
Unlock full evidence details
StrongDecrease
Intact proinsulin
BeaT-2/Sugarburner → Intact proinsulin
BeaT-2/Sugarburner → Intact proinsulin
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
Unlock full evidence analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Evidence Suggest
- HbA1c showed a significant decrease of 0.3%.
- Fasting plasma glucose decreased by 14%.
- Insulin levels decreased by 17%.
Who this applies to
- Adults diagnosed with type 2 diabetes.
- Patients seeking alternative or complementary treatments.
Keep in Mind
- Results may not apply to all diabetes patients.
- Further research is needed to confirm findings.
- Variability in outcomes suggests a complex relationship.
Between the Lines
- Limited sample size may affect generalizability.
- Inconsistent results across different outcomes.
- Lack of long-term follow-up data.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Already have an account?
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on BeaT-2/Sugarburner and Adipokine and Angiogenic Markers, BeaT-2/Sugarburner and Inflammatory Markers.
Related evidence relationships
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention-outcome relationships.
Included in these evidence collections
Curated evidence collections and hubs this study is part of.
Adipokine and Angiogenic Markers Evidence Hub
All studies measuring Adipokine and Angiogenic Markers
1 studies
outcome_hubMeasures Adipokine and Angiogenic Markers as a key outcome.
BeaT-2/Sugarburner Evidence Hub
All studies on BeaT-2/Sugarburner
1 studies
intervention_hubContributes to BeaT-2/Sugarburner evidence base.
Inflammatory Markers Evidence Hub
All studies measuring Inflammatory Markers
1 studies
outcome_hubMeasures Inflammatory Markers as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in the evidence archive
Jump to pre-filtered views in the evidence archive.
All studies on BeaT-2/Sugarburner and Adiponectin
Intervention: BeaT-2/SugarburnerOutcome: Adiponectin
1 results
All studies on BeaT-2/Sugarburner and C-reactive protein
Intervention: BeaT-2/SugarburnerOutcome: C-reactive protein
1 results
All studies on BeaT-2/Sugarburner
Intervention: BeaT-2/Sugarburner
1 results
All studies measuring Adiponectin
Outcome: Adiponectin
1 results
All studies measuring C-reactive protein
Outcome: C-reactive protein
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does BeaT-2/Sugarburner improve adiponectin?
Emerging Evidence
BeaT-2/Sugarburner appears to improve Adiponectin.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Adiponectin
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve c-reactive protein?
Emerging Evidence
BeaT-2/Sugarburner appears to improve C-reactive protein.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
C-reactive protein
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve fasting plasma glucose (fpg)?
Emerging Evidence
BeaT-2/Sugarburner appears to improve Fasting Plasma Glucose (FPG).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve HbA1c?
Emerging Evidence
BeaT-2/Sugarburner appears to improve HbA1c.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, archive views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in archive
Open broader archive views for this relationship.
Related research
Read related research summaries.
HRS-7535 improves glycemic control in adults with type 2 diabetesTaichi training improves lung function and blood sugar control in diabetesMagnesium supplementation reduces fasting plasma glucose in older adultsNatural products may improve glycemic control in type 2 diabetesCurcumin may improve inflammation and glycemic control in diabetes
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.